Abstract | OBJECTIVE: METHODS: Consecutive patients with STEMI underwent primary PCI were randomly divided into Cypher group (n = 113) and Excel group (n = 115). The primary endpoints were major adverse cardiac events ( MACE, including death, reinfarction and target vessel revascularization) within 12 months. The second endpoints included late luminal loss and restenosis at 9 months. RESULTS: Angiographic follow-up data at 9 months were available in 43 (38%) patients in Cypher group and 48 (42%) in Excel group. The rates of in- stent restenosis and in-segment restenosis were 2.3% vs. 2.1% (P = 0.937) and 4.7% vs. 6.3% (P = 0.738), respectively. The late luminal loss of in- stent and in-segment were (0.17 ± 0.26) mm vs. (0.18 ± 0.33) mm (P = 0.483) and (0.19 ± 0.36) mm vs. (0.20 ± 0.42) mm (P = 0.419), respectively. There were no significant differences in death (3.5% vs. 2.6%, P = 0.692), reinfarction (1.8% vs. 2.6%, P = 0.658), target vessel revascularization (1.8% vs. 2.6%, P = 0.658), MACE (5.3% vs. 6.1%, P = 0.788) or stent thrombosis (4.4% vs. 3.5%, P = 0.692) at 12 months between Cyper group and Excel group. CONCLUSIONS: Excel and Cypher Select stents may have similar mid-term efficacy and safety in patients with STEMI treated with primary PCI.Further investigation is warranted to validate the long-term efficacy and safety.
|
Authors | Qiang Li, Le-feng Wang, Xin-chun Yang, Yong-gui Ge, Hong-shi Wang, Wei-ming Li, Li Xu, Zhu-hua Ni, Kun Xia |
Journal | Zhonghua xin xue guan bing za zhi
(Zhonghua Xin Xue Guan Bing Za Zhi)
Vol. 38
Issue 10
Pg. 886-90
(Oct 2010)
ISSN: 0253-3758 [Print] China |
PMID | 21176630
(Publication Type: Comparative Study, English Abstract, Journal Article, Randomized Controlled Trial)
|
Chemical References |
|
Topics |
- Aged
- Angioplasty, Balloon, Coronary
(methods)
- Drug-Eluting Stents
- Female
- Humans
- Male
- Middle Aged
- Myocardial Infarction
(therapy)
- Polymers
(chemistry)
- Prospective Studies
- Sirolimus
(administration & dosage, therapeutic use)
- Treatment Outcome
|